Comparison between Galactico Corporate IPO and Novateor Research Laboratories IPO.
Galactico Corporate IPO is a SME Fixed Price IPO proposed to list at BSE SME while Novateor Research Laboratories IPO is a SME Fixed Price proposed to list at BSE SME.
| Galactico Corporate IPO | Novateor Research Laboratories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Aryaman Financial Services Ltd. | First Overseas Capital Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Aryaman Capital Markets Ltd. | Beeline Broking Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Galactico Corporate IPO is up to ₹3.51 Cr whereas the issue size of the Novateor Research Laboratories IPO is up to ₹4.26 Cr. The final issue price of Galactico Corporate IPO is ₹23.00 per share and of Novateor Research Laboratories IPO is ₹24.00 per share.
| Galactico Corporate IPO | Novateor Research Laboratories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹23.00 per share | ₹24.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 6000 shares | 6000 shares |
| Fresh Issue Size | 2,16,000 shares | 17,76,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.50 Cr | up to ₹4.26 Cr |
| OFS Issue Size | 13,08,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹3.01 Cr | up to ₹0.00 Cr |
| Issue Size Total | 15,24,000 shares | 17,76,000 shares |
| Issue Size Total (Amount) | up to ₹3.51 Cr | up to ₹4.26 Cr |
Galactico Corporate IPO opens on Sep 24, 2019, while Novateor Research Laboratories IPO opens on Aug 30, 2019. The closing date of Galactico Corporate IPO and Novateor Research Laboratories IPO is Sep 27, 2019, and Sep 04, 2019, respectively.
| Galactico Corporate IPO | Novateor Research Laboratories IPO | |
|---|---|---|
| Issue Open | Sep 24, 2019 | Aug 30, 2019 |
| Issue Close | Sep 27, 2019 | Sep 04, 2019 |
| Basis Of Allotment (Tentative) | Sep 09, 2019 | |
| Initiation of Refunds (Tentative) | Sep 11, 2019 | |
| Credit of Share (Tentative) | Sep 12, 2019 | |
| Listing date (Tentative) | Oct 09, 2019 | Sep 13, 2019 |
Galactico Corporate IPO P/E ratio is , as compared to Novateor Research Laboratories IPO P/E ratio of .
| Galactico Corporate IPO | Novateor Research Laboratories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99% | 99.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.94% | 60.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹13.18 Cr. | ₹11.60 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Galactico Corporate IPO Retail Individual Investors (RII) are offered 7,62,000 shares while in Novateor Research Laboratories IPO retail investors are offered 7,62,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Galactico Corporate IPO and in Novateor Research Laboratories IPO.
| Galactico Corporate IPO | Novateor Research Laboratories IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 84,000 shares | 96,000 shares |
| QIB | 0 shares | |
| NII | 7,62,000 shares | 8,88,000 shares |
| RII | 7,62,000 shares | 8,88,000 shares |
| Employee | 0 shares | |
| Total | 15,24,000 shares | 17,76,000 shares |
Galactico Corporate IPO subscribed 1.16x in total, whereas Novateor Research Laboratories IPO subscribed 1.24x.
| Galactico Corporate IPO | Novateor Research Laboratories IPO | |
|---|---|---|
| NII (times) | 1.76x | 1.80x |
| RII (times) | 0.56x | 0.67x |
| Total (times) | 1.16x | 1.24x |
